Related Experiment Videos

Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene

L L Wessner1, M Fan, D O Schaeffer

  • 1Department of Pathology, University of Tennessee College of Veterinary Medicine, Knoxville 37901, USA.

Carcinogenesis
|July 1, 1996
PubMed

Insights

Cytochrome P450 family 1 subfamily A member 1 (Cyp1a1) expression influences cancer risk by affecting polycyclic aromatic hydrocarbon (PAH) metabolism. This study shows Cyp1a1 activity is key in PAH-induced mutations and tumor formation in mice.

Area of Science:

  • Pharmacogenetics
  • Chemical carcinogenesis
  • Molecular toxicology

Background:

  • Polycyclic aromatic hydrocarbons (PAHs) are environmental carcinogens requiring metabolic activation.
  • Cytochrome P450 family 1 subfamily A member 1 (Cyp1a1) plays a crucial role in metabolizing PAHs into reactive intermediates.
  • Individual susceptibility to PAH-induced cancers varies, potentially due to differences in Cyp1a1 expression.

Purpose of the Study:

  • To investigate the role of Cyp1a1 expression in the formation of Ki-ras mutations in lung tumors.
  • To determine the impact of transplacental exposure to PAHs on tumor development in a pharmacogenetic mouse model.

Main Methods:

  • Utilized a pharmacogenetic mouse model with varying Cyp1a1 responsiveness (B6D2F1 x DBA backcross).
  • Administered 3-methylcholanthrene (MC), a PAH, via intraperitoneal injection to pregnant mice on day 17 of gestation.
  • Analyzed Ki-ras gene mutations (exons 1 and 2) in lung tumors using allele-specific oligonucleotide hybridization (ASO) and sequencing.

Main Results:

  • Responsive offspring exposed to higher MC doses showed significantly higher incidences of lung tumors compared to nonresponsive littermates.
  • Male responsive mice also exhibited a significantly increased incidence of liver tumors.
  • Eighty-one percent of screened lung tumors (13/16) had point mutations in Ki-ras codons 12 or 13, primarily GGT→GTT and GGT→TGT transversions.

Conclusions:

  • Cyp1a1 plays a critical role in modulating susceptibility to PAH-induced cancer formation.
  • Metabolic activation by Cyp1a1 generates reactive intermediates that can lead to activating mutations in oncogenes like Ki-ras.
  • Genetic variations in Cyp1a1 influence individual risk for chemically induced cancers.

Related Concept Videos